HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Karyotype of peripheral blood lymphocytes in patients treated for Hodgkin disease].

Abstract
Peripheral lymphocyte chromosomes were analyzed in 55 consecutive patients with complete remission after treatment for Hodgkin's disease. In 8 patients, observed metaphases were too few in number. The other 47 patients, 29 men and 18 women, had been off all therapy for 53 months (median 41, ext. 1 to 250 months). The mean interval since the diagnosis was 78 months (median: 73 months) and the mean age at the time of chromosome analysis was 38 years (median: 34, ext. 10-78 years). No patient had either a preleukemic syndrome or leukemia. In contrast to karyotypes in normal controls and previously untreated patients, abnormal cells, hypodiploid, hyperdiploid and tetradiploid cells were more frequent. But neither monosomy 5 or 7 nor trisomy 8 were observed. Intrachromosomal rearrangements (gaps, breaks...) were significantly more frequent (12% vs 5% in untreated patients) particularly on chromosomes 1 and 2. Interchromosomal rearrangements were also numerous (1,25%) but no cells showed any specific translocation for malignant hemopathy. Chromosomal aberrations do not seem closely associated with treatments but influenced by the post-diagnosis interval and the factors present at the time of primary treatment.
AuthorsP Cappelaere, J L Lai, A Caty, M Deminatti, M C Demaille
JournalBulletin du cancer (Bull Cancer) Vol. 70 Issue 1 Pg. 31-9 ( 1983) ISSN: 0007-4551 [Print] France
Vernacular TitleLe caryotype des lymphocytes sanguins périphériques des hodgkiniens traités.
PMID6839032 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
Topics
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents (pharmacology)
  • Child
  • Child, Preschool
  • Chromosome Aberrations (chemically induced, drug effects)
  • Chromosome Disorders
  • Chromosomes, Human (drug effects)
  • Female
  • Hodgkin Disease (blood, drug therapy)
  • Humans
  • Karyotyping
  • Lymphocytes (analysis)
  • Male
  • Middle Aged
  • Ploidies (drug effects)
  • Preleukemia (chemically induced)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: